Martinez Julian, Gordon Taylor M, Strath Scott J
Department of Kinesiology, University of Wisconsin-Milwaukee, Milwaukee, WI 53201-0413, USA.
J Phys Med Rehabil. 2021;3(2):73-90. doi: 10.33696/rehabilitation.3.022.
Functionally limiting health conditions have a high rate of prevalence worldwide and incur a significant amount of economic burden. Physical activity (PA) can prevent the onset of these conditions and alleviate economic burden by reducing symptoms, but a large portion of these individuals do not engage in health enhancing PA. Consumer wearable physical activity monitors (WPAM) are tools that have become increasingly popular within the past few years and could provide a means to improve PA levels for individuals with health conditions that cause functional limitations. This review reports on the validity of PA outcomes, feasibility and utility, and intervention/promotion effectiveness for consumer WPAM in functionally limited clinical populations. 2250 records from January 2018 to July 2021 were retrieved from PubMed, Web of Science, SPORTDiscus and CINAHL with 656 records being duplicates and 23 records passing a full-text article review. Studies included within the review looked at individuals with osteoarthritis, rheumatoid arthritis, axial spondyloarthritis, multiple sclerosis, Parkinson's disease, ischemic stroke and peripheral arterial disease. The most popular brand of consumer WPAM was Fitbit. Validation studies for consumer WPAM were primarily focused on step counts showing overestimations for daily step counts and over- and under-estimations occurring within shorter time durations depending on step cadence. Wrist worn WPAM are the most feasible for functionally limited clinical populations with widespread utilization for associating clinically relevant outcomes with PA levels but they have limited validation to confirm their accuracy and precision in measurement. Interventions included used a mixture of a WPAM and other behavior change techniques to improve PA levels for clinical populations and show promising effectiveness. Future work is warranted on determining the validity of PA outcomes from WPAM determined to be feasible in select clinical populations and creating interventions looking at which features of a consumer WPAM intervention promote PA.
功能受限的健康状况在全球范围内患病率很高，并产生了巨大的经济负担。体育活动（PA）可以预防这些状况的发生，并通过减轻症状来减轻经济负担，但这些人中很大一部分没有进行有益健康的体育活动。消费者可穿戴体育活动监测器（WPAM）是在过去几年中越来越受欢迎的工具，可以为患有导致功能受限的健康状况的个人提供提高体育活动水平的方法。本综述报告了消费者WPAM在功能受限的临床人群中的体育活动结果的有效性、可行性和实用性，以及干预/促进效果。从PubMed、科学网、SPORTDiscus和CINAHL检索了2018年1月至2021年7月的2250条记录，其中656条记录为重复记录，23条记录通过了全文文章评审。综述中纳入的研究观察了骨关节炎、类风湿性关节炎、轴性脊柱关节炎、多发性硬化症、帕金森病、缺血性中风和外周动脉疾病患者。最受欢迎的消费者WPAM品牌是Fitbit。消费者WPAM的验证研究主要集中在步数计数上，结果显示每日步数计数存在高估，并且根据步频，在较短时间内会出现高估和低估。腕戴式WPAM对功能受限的临床人群最可行，广泛用于将临床相关结果与体育活动水平相关联，但它们在确认测量的准确性和精确性方面的验证有限。干预措施包括将WPAM与其他行为改变技术结合使用，以提高临床人群的体育活动水平，并显示出有前景的效果。有必要开展未来工作，以确定在特定临床人群中被确定为可行的WPAM的体育活动结果的有效性，并开展干预措施，研究消费者WPAM干预的哪些特征能促进体育活动。
